Back
ImmunityBio, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Sell
30
IBRX
ImmunityBio, Inc.
Last Price:
$2.37
Seasonality Move:
74.15%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBRX is experiencing slight buying pressure.
ImmunityBio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.22 | Buy |
| 20-day SMA: | 2.14 | Buy |
| 50-day SMA: | 2.32 | Sell |
| 200-day SMA: | 2.61 | Sell |
| 8-day EMA: | 2.22 | Buy |
| 20-day EMA: | 2.18 | Buy |
| 50-day EMA: | 1.9 | Buy |
| 200-day EMA: | 0.86 | Buy |
ImmunityBio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 53.18 | Buy |
| Chaikin Money Flow: | 1490833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.05 - 2.25) | Buy |
| Bollinger Bands (100): | (2.21 - 2.65) | Sell |
ImmunityBio, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ImmunityBio, Inc. Stock
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 2.29 while IBRX 8-day simple moving average is 2.22, which is a Buy signal.
-
The stock price of IBRX is 2.29 while ImmunityBio, Inc. 20-day SMA is 2.14, which makes it a Buy.
-
ImmunityBio, Inc. 50-day simple moving average is 2.32 while IBRX share price is 2.29, making it a Sell technically.
-
IBRX stock price is 2.29 and ImmunityBio, Inc. 200-day simple moving average is 2.61, creating a Sell signal.
IBRX Technical Analysis vs Fundamental Analysis
Sell
30
ImmunityBio, Inc. (IBRX)
is a Sell
Is ImmunityBio, Inc. a Buy or a Sell?
-
ImmunityBio, Inc. stock is rated a SellThe current ImmunityBio, Inc. [IBRX] share price is $2.29. The Score for IBRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
ImmunityBio, Inc. Stock Info
Market Cap:
2.3B
Price in USD:
2.29
Share Volume:
6.8M
ImmunityBio, Inc. 52-Week Range
52-Week High:
5.12
52-Week Low:
1.83
Sell
30
ImmunityBio, Inc. (IBRX)
is a Sell
ImmunityBio, Inc. Share Price Forecast
-
What is the ImmunityBio, Inc. stock price today?The ImmunityBio, Inc. stock price is 2.29 USD today.
-
Will IBRX stock go up or go down?ImmunityBio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ImmunityBio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio, Inc. is overvalued.
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 2.29 while IBRX 8-day exponential moving average is 2.22, which is a Buy signal.
-
The stock price of IBRX is 2.29 while ImmunityBio, Inc. 20-day EMA is 2.18, which makes it a Buy.
-
ImmunityBio, Inc. 50-day exponential moving average is 1.90 while IBRX share price is 2.29, making it a Buy technically.
-
IBRX stock price is 2.29 and ImmunityBio, Inc. 200-day simple moving average is 0.86, creating a Buy signal.
Fundamental Analysis of ImmunityBio, Inc.
Is ImmunityBio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.14 per share.
Technical Analysis of ImmunityBio, Inc.
Should I short ImmunityBio, Inc. stock?
-
IBRX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting ImmunityBio, Inc. is a Buy
-
ImmunityBio, Inc. Relative Strength Index (RSI) is 53.18, which suggest ImmunityBio, Inc. is overbought
-
The Bollinger Bands (25) for ImmunityBio, Inc. is (2.05 - 2.25), which suggest ImmunityBio, Inc. is a Sell
-
The Bollinger Bands (100) for ImmunityBio, Inc. is (2.21 - 2.65), which suggest ImmunityBio, Inc. is a Sell
* ImmunityBio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.